| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 217026 | NDA | ACADIA PHARMS INC | 001 | DAYBUE | SOLUTION;ORAL | 200MG/ML | TROFINETIDE | 2023-03-10 | Prescription | Yes | |
| 210793 | NDA | ACADIA PHARMS INC | 001 | NUPLAZID | CAPSULE;ORAL | EQ 34MG BASE | PIMAVANSERIN TARTRATE | 2018-06-28 | Prescription | Yes | |
| 207318 | NDA | ACADIA PHARMS INC | 001 | NUPLAZID | TABLET;ORAL | EQ 17MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | PIMAVANSERIN TARTRATE | 2016-04-29 | Discontinued | No | |
| 002 | NUPLAZID | TABLET;ORAL | EQ 10MG BASE | PIMAVANSERIN TARTRATE | 2016-04-29 | Prescription | Yes |